Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020

BACKGROUND: Timely treatment with neuraminidase inhibitors (NAI) can reduce severe outcomes in influenza patients. AIM: We assessed the impact of antiviral treatment on in-hospital deaths of laboratory-confirmed influenza patients in 11 European Union countries from 2010/11 to 2019/20. METHODS: Case...

Descripción completa

Detalles Bibliográficos
Autores principales: Adlhoch, Cornelia, Delgado-Sanz, Concepción, Carnahan, AnnaSara, Larrauri, Amparo, Popovici, Odette, Bossuyt, Nathalie, Thomas, Isabelle, Kynčl, Jan, Slezak, Pavel, Brytting, Mia, Guiomar, Raquel, Redlberger-Fritz, Monika, Maistre Melillo, Jackie, Melillo, Tanya, van Gageldonk-Lafeber, Arianne B., Marbus, Sierk D., O’Donnell, Joan, Domegan, Lisa, Gomes Dias, Joana, Olsen, Sonja J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Surveillance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881178/
https://www.ncbi.nlm.nih.gov/pubmed/36700868
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.4.2200340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881178/
https://www.ncbi.nlm.nih.gov/pubmed/36700868
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.4.2200340

Ejemplares similares